Among many endogenous mediators, the gasotransmitter hydrogen sulfide (H2S) plays an important role in the regulation of glucose homeostasis. In this article we discuss different functional roles of H2S in several metabolic organs/tissues required in the maintenance of glucose homeostasis.
Recent Advances:
New evidence has emerged revealing the insulin sensitizing role of H2S in adipose tissue and skeletal muscle biology. In addition, H2S was demonstrated to be a potent stimulator of gluconeogenesis via the induction and stimulation of various glucose-producing pathways in the liver.
Critical Issues:
Similar to its other physiological effects, H2S exhibits paradoxical characteristics in the regulation of glucose homeostasis: (1) H2S stimulates glucose production via activation of gluconeogenesis and glycogenolysis in hepatocytes, yet inhibits lipolysis in adipocytes; (2) H2S stimulates glucose uptake into adipocytes and skeletal muscle but inhibits glucose uptake into hepatocytes; (3) H2S inhibits insulin secretion from pancreatic β cells, yet sensitizes insulin signaling and insulin-triggered response in adipose tissues and skeletal muscle. It is also unclear the impact H2S may have on glucose metabolism and utilization by other vital organs, such as the brain.
Future Directions:
Recent reports and ongoing studies lay the foundation for a general, although highly incomplete, understanding of the effect of H2S on regulating glucose homeostasis. In this review, we describe the molecular mechanisms and physiological outcomes of the gasotransmitter H2S on organs and tissues required for homeostatic maintenance of blood glucose. Future directions highlighting the H2S-mediated homeostatic control of glucose metabolism under physiological and insulin-resistant conditions are also discussed. Antioxid. Redox Signal. 28, 1463–1482.
Get full access to this article
View all access options for this article.
References
1.
Standards of Medical Care in Diabetes-2017: summary of Revisions. Diabetes Care, 40: S4–S5, 2017.
2.
AhmadA, OlahG, SzczesnyB, WoodME, WhitemanM, and SzaboC. AP39, A mitochondrially targeted hydrogen sulfide donor, exerts protective effects in renal epithelial cells subjected to oxidative stress in vitro and in acute renal injury in vivo. Shock, 45: 88–97, 2016.
3.
AliMY, WhitemanM, LowCM, and MoorePK. Hydrogen sulphide reduces insulin secretion from HIT-T15 cells by a KATP channel-dependent pathway. J Endocrinol, 195: 105–112, 2007.
4.
AsimakopoulouA, PanopoulosP, ChasapisCT, ColettaC, ZhouZ, CirinoG, GiannisA, SzaboC, SpyrouliasGA, and PapapetropoulosA. Selectivity of commonly used pharmacological inhibitors for cystathionine beta synthase (CBS) and cystathionine gamma lyase (CSE). Br J Pharmacol, 169: 922–932, 2013.
5.
BalaV, RajagopalS, KumarDP, NalliAD, MahavadiS, SanyalAJ, GriderJR, and MurthyKS. Release of GLP-1 and PYY in response to the activation of G protein-coupled bile acid receptor TGR5 is mediated by Epac/PLC-ɛ pathway and modulated by endogenous H(2)S. Front Physiol, 5: 420, 2014.
6.
BandyopadhyayG, KanohY, SajanMP, StandaertML, and FareseRV. Effects of adenoviral gene transfer of wild-type, constitutively active, and kinase-defective protein kinase C-λ on insulin-stimulated glucose transport in L6 myotubes. Endocrinology, 141: 4120–4127, 2000.
7.
BarrLA, ShimizuY, LambertJP, NicholsonCK, and CalvertJW. Hydrogen sulfide attenuates high fat diet-induced cardiac dysfunction via the suppression of endoplasmic reticulum stress. Nitric Oxide, 46: 145–156, 2015.
8.
BeauchampROJr., BusJS, PoppJA, BoreikoCJ, and AndjelkovichDA. A critical review of the literature on hydrogen sulfide toxicity. Crit Rev Toxicol, 13: 25–97, 1984.
9.
BenavidesGA, SquadritoGL, MillsRW, PatelHD, IsbellTS, PatelRP, Darley-UsmarVM, DoellerJE, and KrausDW. Hydrogen sulfide mediates the vasoactivity of garlic. Proc Natl Acad Sci U S A, 104: 17977–17982, 2007.
10.
BhambhaniY, BurnhamR, SnydmillerG, and MacLeanI. Effects of 10-ppm hydrogen sulfide inhalation in exercising men and women. Cardiovascular, metabolic, and biochemical responses. J Occup Environ Med, 39: 122–129, 1997.
11.
BhambhaniY, BurnhamR, SnydmillerG, MacLeanI, and MartinT. Effects of 5 ppm hydrogen sulfide inhalation on biochemical properties of skeletal muscle in exercising men and women. Am Ind Hyg Assoc J, 57: 464–468, 1996.
12.
BhambhaniY and SinghM. Physiological effects of hydrogen sulfide inhalation during exercise in healthy men. J Appl Physiol (1985), 71: 1872–1877, 1991.
13.
BhuiyanAI, PapajaniVT, PaciM, and MelinoS. Glutathione-garlic sulfur conjugates: slow hydrogen sulfide releasing agents for therapeutic applications. Molecules, 20: 1731–1750, 2015.
14.
BlachierF, DavilaAM, MimounS, BenettiPH, AtanasiuC, AndriamihajaM, BenamouzigR, BouillaudF, and TomeD. Luminal sulfide and large intestine mucosa: friend or foe?. Amino Acids, 39: 335–347, 2010.
BlouetC, MariottiF, MikogamiT, TomeD, and HuneauJF. Meal cysteine improves postprandial glucose control in rats fed a high-sucrose meal. J Nutr Biochem, 18: 519–524, 2007.
17.
BouillaudF and BlachierF. Mitochondria and sulfide: a very old story of poisoning, feeding, and signaling?. Antioxid Redox Signal, 15: 379–391, 2011.
18.
BrancaleoneV, RoviezzoF, VelleccoV, De GruttolaL, BucciM, and CirinoG. Biosynthesis of H2S is impaired in non-obese diabetic (NOD) mice. Br J Pharmacol, 155: 673–680, 2008.
19.
BucciM, PapapetropoulosA, VelleccoV, ZhouZ, PyriochouA, RoussosC, RoviezzoF, BrancaleoneV, and CirinoG. Hydrogen sulfide is an endogenous inhibitor of phosphodiesterase activity. Arterioscler Thromb Vasc Biol, 30: 1998–2004, 2010.
20.
ButeauJ, FoisyS, JolyE, and PrentkiM. Glucagon-like peptide 1 induces pancreatic beta-cell proliferation via transactivation of the epidermal growth factor receptor. Diabetes, 52: 124–132, 2003.
21.
CaiJ, ShiX, WangH, FanJ, FengY, LinX, YangJ, CuiQ, TangC, XuG, and GengB. Cystathionine gamma lyase-hydrogen sulfide increases peroxisome proliferator-activated receptor gamma activity by sulfhydration at C139 site thereby promoting glucose uptake and lipid storage in adipocytes. Biochim Biophys Acta, 1861: 419–429, 2016.
22.
CarnagarinR, DharmarajanAM, and DassCR. Molecular aspects of glucose homeostasis in skeletal muscle—a focus on the molecular mechanisms of insulin resistance. Mol Cell Endocrinol, 417: 52–62, 2015.
23.
CerdaMM, HammersMD, EarpMS, ZakharovLN, and PluthMD. Applications of synthetic organic tetrasulfides as H2S donors. Org Lett, 19: 2314–2317, 2017.
24.
ChangT, UntereinerA, LiuJ, and WuL. Interaction of methylglyoxal and hydrogen sulfide in rat vascular smooth muscle cells. Antioxid Redox Signal, 12: 1093–1100, 2010.
25.
ChaoC, ZatarainJR, DingY, ColettaC, MrazekAA, DruzhynaN, JohnsonP, ChenH, HellmichJL, AsimakopoulouA, YanagiK, OlahG, SzoleczkyP, TöröG, BohanonFJ, CheemaM, LewisR, EckelbargerD, AhmadA, MódisK, UntereinerA, SzczesnyB, PapapetropoulosA, ZhouJ, HellmichMR, and SzaboC. Cystathionine-β-synthase inhibition for colon cancer: enhancement of the efficacy of aminooxyacetic acid via the prodrug approach. Mol Med, 22: 361–379, 2016.
26.
ChenNC, YangF, CapecciLM, GuZ, SchaferAI, DuranteW, YangXF, and WangH. Regulation of homocysteine metabolism and methylation in human and mouse tissues. Faseb J, 24: 2804–2817, 2010.
27.
CooperCE and BrownGC. The inhibition of mitochondrial cytochrome oxidase by the gases carbon monoxide, nitric oxide, hydrogen cyanide and hydrogen sulfide: chemical mechanism and physiological significance. J Bioenerg Biomembr, 40: 533–539, 2008.
28.
DaweGS, HanSP, BianJS, and MoorePK. Hydrogen sulphide in the hypothalamus causes an ATP-sensitive K+ channel-dependent decrease in blood pressure in freely moving rats. Neuroscience, 152: 169–177, 2008.
29.
De CiccoP, PanzaE, ArmogidaC, ErcolanoG, Taglialatela-ScafatiO, ShokoohiniaY, CamerlingoR, PirozziG, CalderoneV, CirinoG, and IanaroA. The Hydrogen sulfide releasing molecule acetyl deacylasadisulfide inhibits metastatic melanoma. Front Pharmacol, 8: 65, 2017.
30.
DeFronzoRA and TripathyD. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care, 32Suppl 2: S157–S163, 2009.
31.
DesaiKM, ChangT, UntereinerA, and WuL. Hydrogen sulfide and the metabolic syndrome. Expert Rev Clin Pharmacol, 4: 63–73, 2011.
32.
DharA, DharI, JiangB, DesaiKM, and WuL. Chronic methylglyoxal infusion by minipump causes pancreatic beta-cell dysfunction and induces type 2 diabetes in Sprague-Dawley rats. Diabetes, 60: 899–908, 2011.
33.
DuJT, LiW, YangJY, TangCS, LiQ, and JinHF. Hydrogen sulfide is endogenously generated in rat skeletal muscle and exerts a protective effect against oxidative stress. Chin Med J (Engl), 126: 930–936, 2013.
34.
EnokidoY, SuzukiE, IwasawaK, NamekataK, OkazawaH, and KimuraH. Cystathionine beta-synthase, a key enzyme for homocysteine metabolism, is preferentially expressed in the radial glia/astrocyte lineage of developing mouse CNS. FASEB J, 19: 1854–1856, 2005.
35.
FengX, ChenY, ZhaoJ, TangC, JiangZ, and GengB. Hydrogen sulfide from adipose tissue is a novel insulin resistance regulator. Biochem Biophys Res Commun, 380: 153–159, 2009.
36.
FinckBN and KellyDP. PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J Clin Invest, 116: 615–622, 2006.
37.
FontanaL, PartridgeL, and LongoVD. Extending healthy life span—from yeast to humans. Science, 328: 321–326, 2010.
38.
FuM, ZhangW, WuL, YangG, LiH, and WangR. Hydrogen sulfide (H2S) metabolism in mitochondria and its regulatory role in energy production. Proc Natl Acad Sci U S A, 109: 2943–2948, 2012.
39.
FullertonMD, GalicS, MarcinkoK, SikkemaS, PulinilkunnilT, ChenZP, O'NeillHM, FordRJ, PalanivelR, O'BrienM, HardieDG, MacaulaySL, SchertzerJD, DyckJRB, van DenderenBJ, KempBE, and SteinbergGR. Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin. Nat Med, 19: 1649–1654, 2013.
40.
GaoY, YaoX, ZhangY, LiW, KangK, SunL, and SunX. The protective role of hydrogen sulfide in myocardial ischemia-reperfusion-induced injury in diabetic rats. Int J Cardiol, 152: 177–183, 2011.
41.
GengB, CaiB, LiaoF, ZhengY, ZengQ, FanX, GongY, YangJ, CuiQh, TangC, and XuGH. Increase or decrease hydrogen sulfide exert opposite lipolysis, but reduce global insulin resistance in high fatty diet induced obese mice. PLoS One, 8: e73892, 2013.
42.
GeroD, TorregrossaR, PerryA, WatersA, Le-TrionnaireS, WhatmoreJL, WoodM, and WhitemanM. The novel mitochondria-targeted hydrogen sulfide (H2S) donors AP123 and AP39 protect against hyperglycemic injury in microvascular endothelial cells in vitro. Pharmacol Res, 113: 186–198, 2016.
43.
GoubernM, AndriamihajaM, NubelT, BlachierF, and BouillaudF. Sulfide, the first inorganic substrate for human cells. FASEB J, 21: 1699–1706, 2007.
44.
GraySM, MeijerRI, and BarrettEJ. Insulin regulates brain function, but how does it get there?. Diabetes, 63: 3992–3997, 2014.
45.
GreenbergAS and ObinMS. Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr, 83: 461s–465s, 2006.
46.
GroegerM, MatalloJ, McCookO, WagnerF, WachterU, BastianO, GiererS, ReichV, StahlB, Huber-LangM, SzaboC, GeorgieffM, RadermacherP, CalziaE, and WagnerK. Temperature and cell-type dependency of sulfide effects on mitochondrial respiration. Shock, 38: 367–374, 2012.
47.
GuanQ, ZhangY, YuC, LiuY, GaoL, and ZhaoJ. Hydrogen sulfide protects against high-glucose-induced apoptosis in endothelial cells. J Cardiovasc Pharmacol, 59: 188–193, 2012.
48.
GuilhermeA, VirbasiusJV, PuriV, and CzechMP. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol, 9: 367–377, 2008.
49.
GunawardeneAR, CorfeBM, and StatonCA. Classification and functions of enteroendocrine cells of the lower gastrointestinal tract. Int J Exp Pathol, 92: 219–231, 2011.
50.
GuoR, WuZ, JiangJ, LiuC, WuB, LiX, LiT, MoH, HeS, LiS, YanH, HuangR, YouQ, and WuK. New mechanism of lipotoxicity in diabetic cardiomyopathy: deficiency of Endogenous H2S Production and ER stress. Mech Ageing Dev, 162: 46–52, 2017.
51.
HargroveJL, TrotterJF, AshlineHC, and KrishnamurtiPV. Experimental diabetes increases the formation of sulfane by transsulfuration and inactivation of tyrosine aminotransferase in cytosols from rat liver. Metabolism, 38: 666–672, 1989.
52.
HaydenLJ, GoedenH, and RothSH. Exposure to low levels of hydrogen sulfide elevates circulating glucose in maternal rats. J Toxicol Environ Health, 31: 45–52, 1990.
53.
HellmichMR, ColettaC, ChaoC, and SzaboC. The therapeutic potential of cystathionine beta-synthetase/hydrogen sulfide inhibition in cancer. Antioxid Redox Signal, 22: 424–448, 2015.
54.
HineC, HarputlugilE, ZhangY, RuckenstuhlC, LeeBC, BraceL, LongchampA, Trevino-VillarrealJH, MejiaP, OzakiCK, WangR, GladyshevVN, MadeoF, MairWB, and MitchellJR. Endogenous hydrogen sulfide production is essential for dietary restriction benefits. Cell, 160: 132–144, 2015.
55.
HolzerP, ReichmannF, and FarziA. Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut-brain axis. Neuropeptides, 46: 261–274, 2012.
56.
HsuCC, YenHF, YinMC, TsaiCM, and HsiehCH. Five cysteine-containing compounds delay diabetic deterioration in Balb/cA mice. J Nutr, 134: 3245–3249, 2004.
57.
HuN, DongM, and RenJ. Hydrogen sulfide alleviates cardiac contractile dysfunction in an Akt2-knockout murine model of insulin resistance: role of mitochondrial injury and apoptosis. Am J Physiol Regul Integr Comp Physiol, 306: R761–R771, 2014.
58.
HuangQ, SparatoreA, Del SoldatoP, WuL, and DesaiK. Hydrogen sulfide releasing aspirin, ACS14, attenuates high glucose-induced increased methylglyoxal and oxidative stress in cultured vascular smooth muscle cells. PLoS One, 9: e97315, 2014.
59.
HwangSY, SarnaLK, and Siow YLO K. High-fat diet stimulates hepatic cystathionine beta-synthase and cystathionine gamma-lyase expression. Can J Physiol Pharmacol, 91: 913–919, 2013.
60.
JacobsRL, HouseJD, BrosnanME, and BrosnanJT. Effects of streptozotocin-induced diabetes and of insulin treatment on homocysteine metabolism in the rat. Diabetes, 47: 1967–1970, 1998.
61.
JainSK, BullR, RainsJL, BassPF, LevineSN, ReddyS, McVieR, and BocchiniJA. Low levels of hydrogen sulfide in the blood of diabetes patients and streptozotocin-treated rats causes vascular inflammation?. Antioxid Redox Signal, 12: 1333–1337, 2010.
62.
JainSK, VelusamyT, CroadJL, RainsJL, and BullR. L-cysteine supplementation lowers blood glucose, glycated hemoglobin, CRP, MCP-1, and oxidative stress and inhibits NF-kappaB activation in the livers of Zucker diabetic rats. Free Radic Biol Med, 46: 1633–1638, 2009.
63.
JuY, UntereinerA, WuL, and YangG. HS-induced S-sulfhydration of pyruvate carboxylase contributes to gluconeogenesis in liver cells. Biochim Biophys Acta, 1850: 2293–2303, 2015.
64.
KabilO, VitvitskyV, XieP, and BanerjeeR. The quantitative significance of the transsulfuration enzymes for H2S production in murine tissues. Antioxid Redox Signal, 15: 363–372, 2011.
KanekoY, KimuraT, TaniguchiS, SoumaM, KojimaY, KimuraY, KimuraH, and NikiI. Glucose-induced production of hydrogen sulfide may protect the pancreatic beta-cells from apoptotic cell death by high glucose. FEBS Lett, 583: 377–382, 2009.
67.
KanekoY, KimuraY, KimuraH, and NikiI. L-cysteine inhibits insulin release from the pancreatic beta-cell: possible involvement of metabolic production of hydrogen sulfide, a novel gasotransmitter. Diabetes, 55: 1391–1397, 2006.
68.
This reference has been deleted.
69.
KhanAH and PessinJE. Insulin regulation of glucose uptake: a complex interplay of intracellular signalling pathways. Diabetologia, 45: 1475–1483, 2002.
70.
KimKH, LeeHJ, JeongSJ, LeeHJ, LeeEO, KimHS, ZhangY, RyuSY, LeeMH, LuJ, and KimSH. Galbanic acid isolated from Ferula assafoetida exerts in vivo anti-tumor activity in association with anti-angiogenesis and anti-proliferation. Pharm Res, 28: 597–609, 2011.
71.
KimuraH. Hydrogen sulfide as a neuromodulator. Mol Neurobiol, 26: 13–19, 2002.
72.
KolditzCI and LanginD. Adipose tissue lipolysis. Curr Opin Clin Nutr Metab Care, 13: 377–381, 2010.
73.
KotaniK, OgawaW, MatsumotoM, KitamuraT, SakaueH, HinoY, MiyakeK, SanoW, AkimotoK, OhnoS, and KasugaM. Requirement of atypical protein kinase clambda for insulin stimulation of glucose uptake but not for Akt activation in 3T3-L1 adipocytes. Mol Cell Biol, 18: 6971–6982, 1998.
74.
LagoutteE, MimounS, AndriamihajaM, ChaumontetC, BlachierF, and BouillaudF. Oxidation of hydrogen sulfide remains a priority in mammalian cells and causes reverse electron transfer in colonocytes. Biochim Biophys Acta, 1797: 1500–1511, 2010.
75.
LiL, WhitemanM, GuanYY, NeoKL, ChengY, LeeSW, ZhaoY, BaskarR, TanCH, and MoorePK. Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide. Circulation, 117: 2351–2360, 2008.
76.
LiangD, WuH, WongMW, and HuangD. Diallyl trisulfide is a fast H2S donor, but diallyl disulfide is a slow one: the reaction pathways and intermediates of glutathione with polysulfides. Org Lett, 17: 4196–4199, 2015.
77.
LindenDR, LevittMD, FarrugiaG, and SzurszewskiJH. Endogenous production of H2S in the gastrointestinal tract: still in search of a physiologic function. Antioxid Redox Signal, 12: 1135–1146, 2010.
78.
LiuQ, WangS, and CaiL. Diabetic cardiomyopathy and its mechanisms: role of oxidative stress and damage. J Diabetes Investig, 5: 623–634, 2014.
79.
LiuQ, XuWG, LuoY, HanFF, YaoXH, YangTY, ZhangY, PiWF, and GuoXJ. Cigarette smoke-induced skeletal muscle atrophy is associated with up-regulation of USP-19 via p38 and ERK MAPKs. J Cell Biochem, 112: 2307–2316, 2011.
80.
LopaschukGD, BelkeDD, GambleJ, ItoiT, and SchonekessBO. Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim Biophys Acta, 1213: 263–276, 1994.
81.
MancardiD, PennaC, MerlinoA, Del SoldatoP, WinkDA, and PagliaroP. Physiological and pharmacological features of the novel gasotransmitter: hydrogen sulfide. Biochim Biophys Acta, 1787: 864–872, 2009.
82.
ManiS, LiH, UntereinerA, WuL, YangG, AustinRC, DickhoutJG, LhotakS, MengQH, and WangR. Decreased endogenous production of hydrogen sulfide accelerates atherosclerosis. Circulation, 127: 2523–2534, 2013.
83.
ManiS, LiH, YangG, WuL, and WangR. Deficiency of cystathionine gamma-lyase and hepatic cholesterol accumulation during mouse fatty liver development. Sci Bull, 60: 336–347, 2015.
84.
ManiS, YangG, and WangR. A critical life-supporting role for cystathionine gamma-lyase in the absence of dietary cysteine supply. Free Radic Biol Med, 50: 1280–1287, 2011.
85.
MannaP, GungorN, McVieR, and JainSK. Decreased cystathionine-gamma-lyase (CSE) activity in livers of type 1 diabetic rats and peripheral blood mononuclear cells (PBMC) of type 1 diabetic patients. J Biol Chem, 289: 11767–11778, 2014.
86.
MannaP and JainSK. Hydrogen sulfide and L-cysteine increase phosphatidylinositol 3,4,5-trisphosphate (PIP3) and glucose utilization by inhibiting phosphatase and tensin homolog (PTEN) protein and activating phosphoinositide 3-kinase (PI3K)/serine/threonine protein kinase (AKT)/protein kinase Czeta/lambda (PKCzeta/lambda) in 3T3l1 adipocytes. J Biol Chem, 286: 39848–39859, 2011.
87.
MannaP and JainSK. Vitamin D up-regulates glucose transporter 4 (GLUT4) translocation and glucose utilization mediated by cystathionine-gamma-lyase (CSE) activation and H2S formation in 3T3 L1 adipocytes. J Biol Chem, 287: 42324–42332, 2012.
88.
MódisK, AsimakopoulouA, ColettaC, PapapetropoulosA, and SzaboC. Oxidative stress suppresses the cellular bioenergetic effect of the 3-mercaptopyruvate sulfurtransferase/hydrogen sulfide pathway. Biochem Biophys Res Commun, 433: 401–407, 2013.
89.
MódisK, BosEM, CalziaE, van GoorH, ColettaC, PapapetropoulosA, HellmichMR, RadermacherP, BouillaudF, and SzaboC. Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part II. Pathophysiological and therapeutic aspects. Br J Pharmacol, 171: 2123–2146, 2014.
90.
MódisK, ColettaC, ErdelyiK, PapapetropoulosA, and SzaboC. Intramitochondrial hydrogen sulfide production by 3-mercaptopyruvate sulfurtransferase maintains mitochondrial electron flow and supports cellular bioenergetics. FASEB J, 27: 601–611, 2013.
91.
MódisK, JuY, AhmadA, UntereinerAA, AltaanyZ, WuL, SzaboC, and WangR. S-Sulfhydration of ATP synthase by hydrogen sulfide stimulates mitochondrial bioenergetics. Pharmacol Res, 113: 116–124, 2016.
92.
MódisK, KarimiZ, and WangR. Regulation of liver mitochondrial function by hydrogen sulfide. In: Mitochondria in Liver Disease edited by HanD, and KaplowitzN. Boca Raton, FL: CRC Press, 2015, pp. 105–140.
93.
MojsovS. Glucagon-like peptide-1 (GLP-1) and the control of glucose metabolism in mammals and Teleost Fish1. Am Zool, 40: 246–258, 2015.
94.
MooreMC, CoateKC, WinnickJJ, AnZ, and CherringtonAD. Regulation of hepatic glucose uptake and storage in vivo. Adv Nutr, 3: 286–294, 2012.
95.
MorikawaT, KajimuraM, NakamuraT, HishikiT, NakanishiT, YukutakeY, NagahataY, IshikawaM, HattoriK, TakenouchiT, TakahashiT, IshiiI, MatsubaraK, KabeY, UchiyamaS, NagataE, GadallaMM, SnyderSH, and SuematsuM. Hypoxic regulation of the cerebral microcirculation is mediated by a carbon monoxide-sensitive hydrogen sulfide pathway. Proc Natl Acad Sci U S A, 109: 1293–1298, 2012.
96.
MustafaAK, GadallaMM, SenN, KimS, MuW, GaziSK, BarrowRK, YangG, WangR, and SnyderSH. H2S signals through protein S-sulfhydration. Sci Signal, 2: ra72, 2009.
NauckMA, HeimesaatMM, OrskovC, HolstJJ, EbertR, and CreutzfeldtW. Preserved incretin activity of glucagon-like peptide 1 [7–36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J Clin Invest, 91: 301–307, 1993.
99.
NiemanKM, RowlingMJ, GarrowTA, and SchalinskeKL. Modulation of methyl group metabolism by streptozotocin-induced diabetes and all-trans-retinoic acid. J Biol Chem, 279: 45708–45712, 2004.
100.
OlefskyJM and GlassCK. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol, 72: 219–246, 2010.
101.
This reference has been deleted.
102.
PadiyaR, ChowdhuryD, BorkarR, SrinivasR, Pal BhadraM, and BanerjeeSK. Garlic attenuates cardiac oxidative stress via activation of PI3K/AKT/Nrf2-Keap1 pathway in fructose-fed diabetic rat. PLoS One, 9: e94228, 2014.
103.
PaganaKD, PaganaTJ. Chapter 2. In: Mosby's Manual of Diagnostic and Laboratory Tests, 5th ed, edited by PaganaKD, PaganaTJ. St Louis, MO: Elsevier—Health Sciences Division, 2014.
104.
PanZ, WangH, LiuY, YuC, ZhangY, ChenJ, WangX, and GuanQ. Involvement of CSE/H2S in high glucose induced aberrant secretion of adipokines in 3T3-L1 adipocytes. Lipids Health Dis, 13: 155, 2014.
105.
PapapetropoulosA, WhitemanM, and CirinoG. Pharmacological tools for hydrogen sulphide research: a brief, introductory guide for beginners. Br J Pharmacol, 172: 1633–1637, 2015.
106.
PaulBD, SbodioJI, XuR, VandiverMS, ChaJY, SnowmanAM, and SnyderSH. Cystathionine gamma-lyase deficiency mediates neurodegeneration in Huntington's disease. Nature, 509: 96–100, 2014.
107.
PehMT, AnwarAB, NgDS, AtanMS, KumarSD, and MoorePK. Effect of feeding a high fat diet on hydrogen sulfide (H2S) metabolism in the mouse. Nitric Oxide, 41: 138–145, 2014.
108.
PichetteJ and GagnonJ. Implications of hydrogen sulfide in glucose regulation: how H2S can alter glucose homeostasis through metabolic hormones. Oxid Med Cell Longev, 2016: 3285074, 2016.
109.
PorterDW and BaskinSI. The effect of three alpha-keto acids on 3-mercaptopyruvate sulfurtransferase activity. J Biochem Toxicol, 11: 45–50, 1996.
110.
PredmoreBL, LeferDJ, and GojonG. Hydrogen sulfide in biochemistry and medicine. Antioxid Redox Signal, 17: 119–140, 2012.
111.
RöderPV, WuB, LiuY, and HanW. Pancreatic regulation of glucose homeostasis. Exp Mol Med, 48: e219, 2016.
112.
RohE, Song doK, and KimMS. Emerging role of the brain in the homeostatic regulation of energy and glucose metabolism. Exp Mol Med, 48: e216, 2016.
113.
RussellTR. Differentiation of 3T3-L2 fibroblasts into adipose cells in bromodeoxyuridine-suppressed cultures. Proc Natl Acad Sci U S A, 76: 4451–4454, 1979.
114.
SaddikM and LopaschukGD. Myocardial triglyceride turnover and contribution to energy substrate utilization in isolated working rat hearts. J Biol Chem, 266: 8162–8170, 1991.
115.
SaltielAR and KahnCR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature, 414: 799–806, 2001.
116.
SaltielAR and PessinJE. Insulin signaling pathways in time and space. Trends Cell Biol, 12: 65–71, 2002.
SchwartzMW, SeeleyRJ, TschopMH, WoodsSC, MortonGJ, MyersMG, and D'AlessioD. Cooperation between brain and islet in glucose homeostasis and diabetes. Nature, 503: 59–66, 2013.
119.
SelphS, DanaT, BlazinaI, BougatsosC, PatelH, and ChouR. Screening for type 2 diabetes mellitus: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med, 162: 765–776, 2015.
120.
SharmaS, AdrogueJV, GolfmanL, UrayI, LemmJ, YoukerK, NoonGP, FrazierOH, and TaegtmeyerH. Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J, 18: 1692–1700, 2004.
121.
ShenX, CarlstromM, BorniquelS, JadertC, KevilCG, and LundbergJO. Microbial regulation of host hydrogen sulfide bioavailability and metabolism. Free Radic Biol Med, 60: 195–200, 2013.
122.
ShibuyaN, TanakaM, YoshidaM, OgasawaraY, TogawaT, IshiiK, and KimuraH. 3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain. Antioxid Redox Signal, 11: 703–714, 2009.
123.
SjolundK, SandenG, HakansonR, and SundlerF. Endocrine cells in human intestine: an immunocytochemical study. Gastroenterology, 85: 1120–1130, 1983.
124.
SongD, HutchingsS, and PangCC. Chronic N-acetylcysteine prevents fructose-induced insulin resistance and hypertension in rats. Eur J Pharmacol, 508: 205–210, 2005.
125.
SrinivasanS, Bernal-MizrachiE, OhsugiM, and PermuttMA. Glucose promotes pancreatic islet beta-cell survival through a PI 3-kinase/Akt-signaling pathway. Am J Physiol Endocrinol Metab, 283: E784–E793, 2002.
126.
StanleyS, WynneK, McGowanB, and BloomS. Hormonal regulation of food intake. Physiol Rev, 85: 1131–1158, 2005.
127.
StipanukMH and BeckPW. Characterization of the enzymic capacity for cysteine desulphhydration in liver and kidney of the rat. Biochem J, 206: 267–277, 1982.
128.
StregePR, BernardCE, KraichelyRE, MazzoneA, ShaL, BeyderA, GibbonsSJ, LindenDR, KendrickML, SarrMG, SzurszewskiJH, and FarrugiaG. Hydrogen sulfide is a partially redox-independent activator of the human jejunum Na+ channel, Nav1.5. Am J Physiol Gastrointest Liver Physiol, 300: G1105–G1114, 2011.
129.
SuzukiK, OlahG, ModisK, ColettaC, KulpG, GeroD, SzoleczkyP, ChangT, ZhouZ, WuL, WangR, PapapetropoulosA, and SzaboC. Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function. Proc Natl Acad Sci U S A, 108: 13829–13834, 2011.
130.
SzaboC, ColettaC, ChaoC, ModisK, SzczesnyB, PapapetropoulosA, and HellmichMR. Tumor-derived hydrogen sulfide, produced by cystathionine-beta-synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancer. Proc Natl Acad Sci U S A, 110: 12474–12479, 2013.
131.
SzaboC, RansyC, ModisK, AndriamihajaM, MurghesB, ColettaC, OlahG, YanagiK, and BouillaudF. Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part I. Biochemical and physiological mechanisms. Br J Pharmacol, 171: 2099–2122, 2014.
132.
TangG, ZhangL, YangG, WuL, and WangR. Hydrogen sulfide-induced inhibition of L-type Ca2+ channels and insulin secretion in mouse pancreatic beta cells. Diabetologia, 56: 533–541, 2013.
133.
TengH, WuB, ZhaoK, YangG, WuL, and WangR. Oxygen-sensitive mitochondrial accumulation of cystathionine beta-synthase mediated by Lon protease. Proc Natl Acad Sci U S A, 110: 12679–12684, 2013.
134.
TsaiCY, PehMT, FengW, DymockBW, and MoorePK. Hydrogen sulfide promotes adipogenesis in 3T3L1 cells. PLoS One, 10: e0119511, 2015.
135.
UfnalM, TomasovaL, DrapalaA, KoszlewskiD, and OstaszewskiR. Na2S, a fast-releasing H2S donor, given as suppository but not parenteral GYY4137, a slow-releasing H2S donor, lowers blood pressure in rats. FASEB J, 31: lb644, 2017.
136.
UntereinerAA, DharA, LiuJ, and WuL. Increased renal methylglyoxal formation with down-regulation of PGC-1alpha-FBPase pathway in cystathionine gamma-lyase knockout mice. PLoS One, 6: e29592, 2011.
137.
UntereinerAA, FuM, ModisK, WangR, JuY, and WuL. Stimulatory effect of CSE-generated H2S on hepatic mitochondrial biogenesis and the underlying mechanisms. Nitric Oxide, 58: 67–76, 2016.
138.
UntereinerAA, OlahG, ModisK, HellmichMR, and SzaboC. H2S-induced S-sulfhydration of lactate dehydrogenase a (LDHA) stimulates cellular bioenergetics in HCT116 colon cancer cells. Biochem Pharmacol, 136: 86–98, 2017.
139.
UntereinerAA, WangR, JuY, and WuL. Decreased gluconeogenesis in the absence of cystathionine gamma-lyase and the underlying mechanisms. Antioxid Redox Signal, 24: 129–140, 2016.
140.
UntereinerAA, WuL, and WangR. The role of carbon monoxide as a gasotransmitter in cardiovascular and metabolic regulation. In: Gasotransmitters: Physiology and Pathophysiology, edited by Anton HermannGFS, ThomasM. Weiger. Berlin: Springer Science & Business Media, 2012. pp. 37–69.
141.
VandiverM and SnyderSH. Hydrogen sulfide: a gasotransmitter of clinical relevance. J Mol Med (Berl), 90: 255–263, 2012.
VeerankiS and TyagiSC. Mechanisms of hyperhomocysteinemia induced skeletal muscle myopathy after ischemia in the CBS-/+ mouse model. Int J Mol Sci, 16: 1252–1265, 2015.
144.
VelmuruganGV, HuangH, SunH, CandelaJ, JaiswalMK, BeamanKD, YamashitaM, PrakriyaM, and WhiteC. Depletion of H2S during obesity enhances store-operated Ca2+ entry in adipose tissue macrophages to increase cytokine production. Sci Signal, 8: ra128, 2015.
145.
VianaAY, SakodaH, AnaiM, FujishiroM, OnoH, KushiyamaA, FukushimaY, SatoY, OshidaY, UchijimaY, KuriharaH, and AsanoT. Role of hepatic AMPK activation in glucose metabolism and dexamethasone-induced regulation of AMPK expression. Diabetes Res Clin Pract, 73: 135–142, 2006.
146.
WallaceJL and WangR. Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter. Nat Rev Drug Discov, 14: 329–345, 2015.
147.
WangR. Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter?. FASEB J, 16: 1792–1798, 2002.
148.
WangR. Physiological implications of hydrogen sulfide: a whiff exploration that blossomed. Physiol Rev, 92: 791–896, 2012.
149.
WangX, JiaX, ChangT, DesaiK, and WuL. Attenuation of hypertension development by scavenging methylglyoxal in fructose-treated rats. J Hypertens, 26: 765–772, 2008.
150.
WhitemanM, GoodingKM, WhatmoreJL, BallCI, MawsonD, SkinnerK, TookeJE, and ShoreAC. Adiposity is a major determinant of plasma levels of the novel vasodilator hydrogen sulphide. Diabetologia, 53: 1722–1726, 2010.
151.
WhitemanM, LiL, RoseP, TanCH, ParkinsonDB, and MoorePK. The effect of hydrogen sulfide donors on lipopolysaccharide-induced formation of inflammatory mediators in macrophages. Antioxid Redox Signal, 12: 1147–1154, 2010.
152.
WildS, RoglicG, GreenA, SicreeR, and KingH. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care, 27: 1047–1053, 2004.
153.
WinnickJJ, AnZ, RamnananCJ, SmithM, IrimiaJM, NealDW, MooreMC, RoachPJ, and CherringtonAD. Hepatic glycogen supercompensation activates AMP-activated protein kinase, impairs insulin signaling, and reduces glycogen deposition in the liver. Diabetes, 60: 398–407, 2011.
154.
World Health Organization (WHO). Global Status Report on Noncommunicable Diseases. Geneva, Switzerland: World Health Organization, 2014.
155.
WuC, OkarDA, KangJ, and LangeAJ. Reduction of hepatic glucose production as a therapeutic target in the treatment of diabetes. Curr Drug Targets Immune Endocr Metabol Disord, 5: 51–59, 2005.
156.
WuL, YangW, JiaX, YangG, DuridanovaD, CaoK, and WangR. Pancreatic islet overproduction of H2S and suppressed insulin release in Zucker diabetic rats. Lab Invest, 89: 59–67, 2009.
157.
XuanA, LongD, LiJ, JiW, ZhangM, HongL, and LiuJ. Hydrogen sulfide attenuates spatial memory impairment and hippocampal neuroinflammation in beta-amyloid rat model of Alzheimer's disease. J Neuroinflammation, 9: 202, 2012.
158.
XueH, YuanP, NiJ, LiC, ShaoD, LiuJ, ShenY, WangZ, ZhouL, ZhangW, HuangY, YuC, WangR, and LuL. H(2)S inhibits hyperglycemia-induced intrarenal renin-angiotensin system activation via attenuation of reactive oxygen species generation. PLoS One, 8: e74366, 2013.
159.
XueR, HaoDD, SunJP, LiWW, ZhaoMM, LiXH, ChenY, ZhuJH, DingYJ, LiuJ, and ZhuYC. Hydrogen sulfide treatment promotes glucose uptake by increasing insulin receptor sensitivity and ameliorates kidney lesions in type 2 diabetes. Antioxid Redox Signal, 19: 5–23, 2013.
160.
YangG, TangG, ZhangL, WuL, and WangR. The pathogenic role of cystathionine gamma-lyase/hydrogen sulfide in streptozotocin-induced diabetes in mice. Am J Pathol, 179: 869–879, 2011.
161.
YangG, WuL, JiangB, YangW, QiJ, CaoK, MengQ, MustafaAK, MuW, ZhangS, SnyderSH, and WangR. H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science, 322: 587–590, 2008.
162.
YangG, YangW, WuL, and WangR. H2S, endoplasmic reticulum stress, and apoptosis of insulin-secreting beta cells. J Biol Chem, 282: 16567–16576, 2007.
163.
YangW, YangG, JiaX, WuL, and WangR. Activation of KATP channels by H2S in rat insulin-secreting cells and the underlying mechanisms. J Physiol, 569: 519–531, 2005.
164.
YusufM, Kwong HuatBT, HsuA, WhitemanM, BhatiaM, and MoorePK. Streptozotocin-induced diabetes in the rat is associated with enhanced tissue hydrogen sulfide biosynthesis. Biochem Biophys Res Commun, 333: 1146–1152, 2005.
165.
ZahaVG and YoungLH. AMP-activated protein kinase regulation and biological actions in the heart. Circ Res, 111: 800–814, 2012.
166.
ZhangL, YangG, TangG, WuL, and WangR. Rat pancreatic level of cystathionine gamma-lyase is regulated by glucose level via specificity protein 1 (SP1) phosphorylation. Diabetologia, 54: 2615–2625, 2011.
167.
ZhangL, YangG, UntereinerA, JuY, WuL, and WangR. Hydrogen sulfide impairs glucose utilization and increases gluconeogenesis in hepatocytes. Endocrinology, 154: 114–126, 2013.
168.
ZhengD, DongS, LiT, YangF, YuX, WuJ, ZhongX, ZhaoY, WangL, XuC, LuF, and ZhangW. Exogenous hydrogen sulfide attenuates cardiac fibrosis through reactive oxygen species signal pathways in experimental diabetes mellitus models. Cell Physiol Biochem, 36: 917–929, 2015.
169.
ZhengY, JiX, JiK, and WangB. Hydrogen sulfide prodrugs-a review. Acta Pharm Sin B, 5: 367–377, 2015.
